Answers are grounded in this paper and cite their sources.
Kawasaki disease (KD) causes coronary artery aneurysms in up to 25% of untreated children, but its transcriptomic resemblance to common febrile illnesses complicates early diagnosis. Current treatments are not directed at a defined disease mechanism, and 10–20% of patients do not respond to initial intravenous immunoglobulin. Using three GEO whole-blood cohorts covering KD, bacterial and viral infection, Henoch-Schönlein purpura, and juvenile idiopathic arthritis, we combined multi-rank non-negative matrix factorization with differential gene correlation analysis to identify hub genes whose co-expression with partner genes differs in KD. KD shared far more differentially expressed genes with bacterial infection (Jaccard index 0.504) than with viral (0.155) or autoimmune (0.017) mimics. Five MCC-ranked hub genes (ITGAM, MMP9, HK3, FCER1G, and CSF3R) were upregulated in KD and showed significant co-expression pairs in KD that were absent in mimics; immune deconvolution hub-gene expression correlated positively with estimated neutrophil fractions and negatively correlated with estimated CD8 + T-cell fractions (HK3: Spearman r = − 0.81). A 5-gene classifier built with TabPFN-V2.5 reached an AUC of 0.889 in external validation. Molecular docking gave S-3304 the most favourable predicted binding energy for MMP9 (− 10.21 kcal/mol), and can used as a candidate drug for the treatment of coronary artery injury and be used in biochemical and preclinical evaluations.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: